These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 17175608)

  • 21. Ten-year risk of cardiovascular incidence related to diabetes, prediabetes, and the metabolic syndrome.
    Liu J; Grundy SM; Wang W; Smith SC; Vega GL; Wu Z; Zeng Z; Wang W; Zhao D
    Am Heart J; 2007 Apr; 153(4):552-8. PubMed ID: 17383293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utility of the metabolic syndrome and its components in the prediction of incident cardiovascular disease: a prospective cohort study.
    Knuiman MW; Hung J; Divitini ML; Davis TM; Beilby JP
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):235-41. PubMed ID: 19238082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular risk in patients with bipolar disorder.
    Garcia-Portilla MP; Saiz PA; Bascaran MT; Martínez A S; Benabarre A; Sierra P; Torres P; Montes JM; Bousoño M; Bobes J;
    J Affect Disord; 2009 Jun; 115(3):302-8. PubMed ID: 18954911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What is metabolic syndrome, and how can it affect my heart health?
    Duke Med Health News; 2010 Oct; 16(10):8. PubMed ID: 21105224
    [No Abstract]   [Full Text] [Related]  

  • 25. Metabolic syndrome in childhood predicts adult cardiovascular disease 25 years later: the Princeton Lipid Research Clinics Follow-up Study.
    Morrison JA; Friedman LA; Gray-McGuire C
    Pediatrics; 2007 Aug; 120(2):340-5. PubMed ID: 17671060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Adipocentrism and cardiovascular risk].
    Trejo Gutiérrez JF
    Arch Cardiol Mex; 2007; 77 Suppl 4():S4-34-8. PubMed ID: 18938694
    [No Abstract]   [Full Text] [Related]  

  • 27. A comparison of components of two definitions of the metabolic syndrome related to cardiovascular disease and all-cause mortality in a cohort study in Thailand.
    Tanomsup S; Aekplakorn W; Sritara P; Woodward M; Yamwong S; Tunlayadechanont S; Tatsaneeyapan A; Lim S; Rajatanavin R
    Diabetes Care; 2007 Aug; 30(8):2138-40. PubMed ID: 17468343
    [No Abstract]   [Full Text] [Related]  

  • 28. Metabolic syndrome: at the crossroads of cardiorenal risk.
    Natali A; Pucci G; Boldrini B; Schillaci G
    J Nephrol; 2009; 22(1):29-38. PubMed ID: 19229816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between the metabolic syndrome and the development of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study-2 (CRISPS2).
    Cheung BM; Wat NM; Man YB; Tam S; Cheng CH; Leung GM; Woo J; Janus ED; Lau CP; Lam TH; Lam KS
    Am J Hypertens; 2008 Jan; 21(1):17-22. PubMed ID: 18091739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of hypertension and other cardiovascular risk factors in patients with metabolic syndrome.
    Suzuki T; Homma S
    Med Clin North Am; 2007 Nov; 91(6):1211-23, x. PubMed ID: 17964917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences in traditional and emerging cardiovascular risk factors of subjects discordantly classified by metabolic syndrome definitions of the International Diabetes Federation and the National Cholesterol Education Program.
    Boronat M; Saavedra P; Varillas VF; Wagner AM; López-Plasencia Y; Alberiche MP; Nóvoa FJ
    Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):417-22. PubMed ID: 18819785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic syndrome: current issues and perspectives.
    Calò LA; Cosentino F; De Luca N
    Panminerva Med; 2006 Mar; 48(1):1-2. PubMed ID: 16633325
    [No Abstract]   [Full Text] [Related]  

  • 33. Metabolic syndrome and cardiovascular disease.
    Qiao Q; Gao W; Zhang L; Nyamdorj R; Tuomilehto J
    Ann Clin Biochem; 2007 May; 44(Pt 3):232-63. PubMed ID: 17456293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular risk assessment in the metabolic syndrome: results from the Prospective Cardiovascular Munster (PROCAM) Study.
    Assmann G; Schulte H; Seedorf U
    Int J Obes (Lond); 2008 May; 32 Suppl 2():S11-6. PubMed ID: 18469834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New insights into understanding cardiometabolic risk. Introduction.
    Fonarow GC; Watson KE
    Rev Cardiovasc Med; 2007; 8 Suppl 4():S1-2. PubMed ID: 17934389
    [No Abstract]   [Full Text] [Related]  

  • 36. Metabolic syndrome may raise memory loss risk. Now, more evidence on the connection between cardiovascular risk factors and cognitive function.
    Duke Med Health News; 2011 Apr; 17(4):5-6. PubMed ID: 21604426
    [No Abstract]   [Full Text] [Related]  

  • 37. The metabolic syndrome: mechanisms, epidemiology, and clinical implications.
    Postgrad Med; 2003 Dec; 114(6 Suppl Managing Metabolic):17-27. PubMed ID: 19667650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Differences between women and men: even through cardiovascular risk factors... role of the gynecologist].
    Berdah J; Amah G
    Gynecol Obstet Fertil; 2009 Feb; 37(2):186-93. PubMed ID: 19211291
    [No Abstract]   [Full Text] [Related]  

  • 39. Obesity: a central risk and cardiovascular target of the cardiometabolic syndrome.
    Frohlich ED
    J Cardiometab Syndr; 2008; 3(3):147-8. PubMed ID: 18983330
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of metabolic syndrome or type II diabetes mellitus on the occurrence of recurrent vascular events in hypertensive patients.
    Vlek AL; van der Graaf Y; Spiering W; Visseren FL;
    J Hum Hypertens; 2008 May; 22(5):358-65. PubMed ID: 18273039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.